Search details
1.
Overlapping Case of Advanced Systemic Sclerosis and IgG4-Related Disease after Autologous Hematopoietic Stem Cell Transplantation.
Medicina (Kaunas)
; 60(3)2024 Mar 18.
Article
in English
| MEDLINE | ID: mdl-38541223
2.
Rare c.302C>T TTR Variant Associated with Transthyretin Amyloidosis.
Medicina (Kaunas)
; 60(2)2024 Jan 30.
Article
in English
| MEDLINE | ID: mdl-38399526
3.
Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group.
Eur J Haematol
; 108(1): 34-44, 2022 Jan.
Article
in English
| MEDLINE | ID: mdl-34536308
4.
Outcomes of relapsed or refractory acute myeloid leukemia patients failing venetoclax-based salvage therapies.
Eur J Haematol
; 106(1): 105-113, 2021 Jan.
Article
in English
| MEDLINE | ID: mdl-32997830
5.
Electrocardiographic left ventricular strain pattern, ST-segment depression and atrial fibrillation at the time of diagnosis of systemic light chain amyloidosis: Incidence and clinical significance.
J Electrocardiol
; 68: 157-163, 2021.
Article
in English
| MEDLINE | ID: mdl-34455115
6.
A Pilot, Exploratory, Randomized, Phase II Safety Study Evaluating Tumor Cell Mobilization and Apheresis Product Contamination in Patients Treated with Granulocyte Colony-Stimulating Factor Alone or Plus Plerixafor.
Biol Blood Marrow Transplant
; 25(1): 34-40, 2019 01.
Article
in English
| MEDLINE | ID: mdl-30149148
7.
Etoposideâ¯+â¯Granulocyte Colony-Stimulating Factor and Optional Plerixafor in Patients Who Failed Chemomobilization with or without Plerixafor.
Biol Blood Marrow Transplant
; 25(7): 1304-1311, 2019 07.
Article
in English
| MEDLINE | ID: mdl-30871977
8.
Time from Symptom Onset to Diagnosis and Treatment among Haematological Malignancies: Influencing Factors and Associated Negative Outcomes.
Medicina (Kaunas)
; 55(6)2019 Jun 03.
Article
in English
| MEDLINE | ID: mdl-31163661
9.
Health-related quality of life and quality-adjusted progression free survival for carfilzomib and dexamethasone maintenance following salvage autologous stem-cell transplantation in patients with multiple myeloma: a randomized phase 2 trial by the Nordic Myeloma Study Group.
J Patient Rep Outcomes
; 8(1): 15, 2024 Feb 05.
Article
in English
| MEDLINE | ID: mdl-38315268
10.
Ixazomib, Lenalidomide, and Dexamethasone (IRD) Treatment with Cytogenetic Risk-Based Maintenance in Transplant-Eligible Myeloma: A Phase 2 Multicenter Study by the Nordic Myeloma Study Group.
Cancers (Basel)
; 16(5)2024 Feb 29.
Article
in English
| MEDLINE | ID: mdl-38473382
11.
Lessons Learned from Early Experiences with Vedolizumab for Steroid-Refractory Acute Graft- versus-Host Disease with Gastrointestinal Involvement.
Biol Blood Marrow Transplant
; 23(9): 1597, 2017 09.
Article
in English
| MEDLINE | ID: mdl-28578009
12.
Multiple Myeloma Immunophenotype Related to Chromosomal Abnormalities Used in Risk Assessment.
Diagnostics (Basel)
; 12(9)2022 Aug 24.
Article
in English
| MEDLINE | ID: mdl-36140450
13.
Adhesion molecule immunophenotype of bone marrow multiple myeloma plasma cells impacts the presence of malignant circulating plasma cells in peripheral blood.
Int J Lab Hematol
; 43(3): 403-408, 2021 Jun.
Article
in English
| MEDLINE | ID: mdl-33185981
14.
Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.
Lancet Haematol
; 8(8): e583-e592, 2021 Aug.
Article
in English
| MEDLINE | ID: mdl-34224668
15.
Venetoclax-based salvage therapy followed by Venetoclax and DLI maintenance vs. FLAG-Ida for relapsed or refractory acute myeloid leukemia after allogeneic stem cell transplantation.
Bone Marrow Transplant
; 56(11): 2804-2812, 2021 11.
Article
in English
| MEDLINE | ID: mdl-34274954
16.
Mitigating arrhythmia risk in Hydroxychloroquine and Azithromycin treated COVID-19 patients using arrhythmia risk management plan.
Int J Cardiol Heart Vasc
; 32: 100685, 2021 Feb.
Article
in English
| MEDLINE | ID: mdl-33335973
17.
Combination of Dabrafenib and Trametinib for the Treatment of Relapsed and Refractory Multiple Myeloma Harboring BRAF V600E Mutation.
Case Rep Hematol
; 2020: 8894031, 2020.
Article
in English
| MEDLINE | ID: mdl-33123389
18.
Diagnostic Challenge of Necrotizing Soft Tissue Infection in a Patient With B Lymphocytic Leukemia.
Cureus
; 12(6): e8387, 2020 Jun 01.
Article
in English
| MEDLINE | ID: mdl-32637269
19.
Anti-α4ß7 integrin monoclonal antibody (vedolizumab) for the treatment of steroid-resistant severe intestinal acute graft-versus-host disease.
Bone Marrow Transplant
; 54(7): 987-993, 2019 07.
Article
in English
| MEDLINE | ID: mdl-30356163
20.
Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study.
Clin Lymphoma Myeloma Leuk
; 18(10): e401-e419, 2018 10.
Article
in English
| MEDLINE | ID: mdl-30030033